Stockscreener 앱 받기
31.89
1.33%
0.42
시간 외 거래:
32.19
0.30
+0.94%
전일 마감가:
$31.47
열려 있는:
$31.6
하루 거래량:
23.03M
Relative Volume:
0.84
시가총액:
$7.38B
수익:
$2.35B
순이익/손실:
$128.37M
주가수익비율:
61.08
EPS:
0.5221
순현금흐름:
$57.42M
1주 성능:
+14.79%
1개월 성능:
+27.31%
6개월 성능:
-8.81%
1년 성능:
-46.17%
1일 변동 폭
$31.03
$33.45
1주일 범위
$26.52
$33.45
52주 변동 폭
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
31.89 | 6.98B | 2.35B | 128.37M | 57.42M | 0.5221 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | JP Morgan | Overweight |
| 2026-03-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2026-03-10 | 업그레이드 | Citigroup | Sell → Neutral |
| 2026-03-09 | 업그레이드 | Needham | Hold → Buy |
| 2026-02-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-01-12 | 개시 | Evercore ISI | In-line |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030 - Stocktwits
3 Market-Beating Stocks with Exciting Potential - The Globe and Mail
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds - Insider Monkey
Hims & Hers (NYSE: HIMS) director acquires 4,613 shares via RSU grants - Stock Titan
Hims & Hers (NYSE: HIMS) director converts 3,656 RSUs into common shares - Stock Titan
Hims & Hers Health (HIMS) director exercises 3,656 RSUs into common stock - Stock Titan
Hims & Hers (NYSE: HIMS) CMO exercises 4,091 RSUs, holds 187,971 shares - Stock Titan
Executive at Hims & Hers (HIMS) receives 3,656 shares from RSU vesting - Stock Titan
Hims & Hers (NYSE: HIMS) director Amoo-Gottfried Kofi Owusu files initial Form 3 - Stock Titan
Hims & Hers (NYSE: HIMS) director exercises RSUs for 14,343 shares - Stock Titan
Hims & Hers (HIMS) director gains 3,656 shares via RSU exercise - Stock Titan
Director at Hims & Hers (NYSE: HIMS) gains 13,696 shares through RSU exercises - Stock Titan
Hims & Hers (HIMS) director exercises 3,656 RSUs into Class A shares - Stock Titan
[8-K] Hims & Hers Health, Inc. Reports Material Event - Stock Titan
(HIMS) Volatility Zones as Tactical Triggers - Stock Traders Daily
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? - Yahoo Finance
Hims & Hers Stock Is Surging Monday: What's Driving The Move? - Benzinga
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Hims & Hers Health (HIMS) up 15.8% since last earnings report: Can it continue? - MSN
Hims & Hers Fell 7% and Wall Street’s Price Target Now Sits Below the Stock - TIKR.com
A Look at Hims & Hers Health Inc (HIMS) After 7.1% Decline -- GF Value $38.10 vs Price $26.82 - GuruFocus
Hims & Hers at The Economist's Inaugural Economics of Obesity and Metabolic Health Summit - Hims & Hers Newsroom
Hims & Hers Health Stock Slides Friday: What's Going On? - Benzinga
Investor relations - HIMS Investor Relations
Hims & Hers Health, Inc. (HIMS) stock drops despite market gains: Important facts to note - MSN
HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic's AI Leap As Lilly, WeightWatchers Turn Up The Heat - Stocktwits
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance
OMCL vs. HIMS: Which Stock Is the Better Value Option? - Yahoo Finance
Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Downgraded to "Strong Sell" Rating by Zacks Research - MarketBeat
Hims & Hers (HIMS) Stock: Investors Reassess Growth Path in Digital Health Weight-Loss Push - parameter.io
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz - The National Law Review
Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look - TechStock²
Hims & Hers Health Options Spot-On: On June 9th, 184.9K Contracts Were Traded, With 1.03 Million Open Interest - Moomoo
Hims & Hers Health Jumps 5.0% Amid Sector-Wide Rally - AlphaStreet
Hims & Hers Stock Edges Higher: What's Going On? - Benzinga
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating - Moomoo
X Square Capital LLC Raises Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.7% R - GuruFocus
HIMS Stock Slips Despite Early Eucalyptus Buyout Close: Analyst Sees 10% Downside On GLP-1 Profit Risks - Stocktwits
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
Investors heavily search Hims & Hers Health, Inc. (HIMS): Here is what you need to know - MSN
HIMS Stock Eyes 2-Week Green Streak: Analyst Sees Nearly 20% Upside On Multi-Year Opportunity In Peptides - Stocktwits
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance
Hims & Hers Health, Inc. $HIMS Shares Sold by Capital World Investors - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Buys 43,826 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS News | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers H - The National Law Review
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today - TradingKey
Hims & Hers Health Stock (HIMS) Opinions on Biotech Sector Momentum - Quiver Quantitative
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Insider Monkey
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
1.13%
자본화:
|
볼륨(24시간):